WHITNEY WALKER: Open Payments
NPI 1245638642 · RIPLEY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 21 payments from 9 companies in 2025. Trend: 2023 $517 · 2024 $397 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $132 |
| Lilly USA, LLC | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Abbott Laboratories | 3 | $44 |
| IBSA Pharma Inc. | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $21 |
Products named: EMBLEM MRI S-ICD, Kerendia, AIRSUPRA, JARDIANCE, LUX-Dx Insertable Cardiac Monitor, Tirosint, REPATHA, FREESTYLE LIBRE 3.
Industry payments across MS — which companies pay providers there.
